[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE0102843D0 - Stabilized oral pharmaceutical composition containing lodide and lodate and method - Google Patents

Stabilized oral pharmaceutical composition containing lodide and lodate and method

Info

Publication number
SE0102843D0
SE0102843D0 SE0102843A SE0102843A SE0102843D0 SE 0102843 D0 SE0102843 D0 SE 0102843D0 SE 0102843 A SE0102843 A SE 0102843A SE 0102843 A SE0102843 A SE 0102843A SE 0102843 D0 SE0102843 D0 SE 0102843D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
lodate
lodide
oral pharmaceutical
composition containing
Prior art date
Application number
SE0102843A
Other languages
English (en)
Other versions
SE0102843L (sv
Inventor
Yongjun Duan
Kirk Dinehart
John Hickey
Jack Kessler
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of SE0102843D0 publication Critical patent/SE0102843D0/sv
Publication of SE0102843L publication Critical patent/SE0102843L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0102843A 1999-02-26 2001-08-27 Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod SE0102843L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/258,062 US6248335B1 (en) 1997-10-29 1999-02-26 Stabilized oral pharmaceutical composition containing iodide and iodate and method
PCT/US2000/004411 WO2000050046A1 (en) 1999-02-26 2000-02-22 Stabilized oral pharmaceutical composition containing iodide and iodate and method

Publications (2)

Publication Number Publication Date
SE0102843D0 true SE0102843D0 (sv) 2001-08-27
SE0102843L SE0102843L (sv) 2001-10-26

Family

ID=22978944

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102843A SE0102843L (sv) 1999-02-26 2001-08-27 Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod

Country Status (19)

Country Link
US (1) US6248335B1 (sv)
JP (1) JP2002537341A (sv)
KR (1) KR100674324B1 (sv)
CN (1) CN1344163A (sv)
AT (1) AT413795B (sv)
AU (1) AU778774B2 (sv)
BR (1) BR0008509A (sv)
CA (1) CA2366679C (sv)
DE (1) DE10084290T1 (sv)
DK (1) DK176595B1 (sv)
ES (1) ES2226514B2 (sv)
FI (1) FI20011703A (sv)
GB (1) GB2364641B (sv)
IL (1) IL144955A (sv)
MX (1) MXPA01008550A (sv)
NO (1) NO20014101L (sv)
SE (1) SE0102843L (sv)
WO (1) WO2000050046A1 (sv)
ZA (1) ZA200106451B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7147873B2 (en) 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
CA2627154C (en) * 2004-12-24 2010-12-21 Council Of Scientific And Industrial Research An improved iodized salt and a process for its preparation
JP4885877B2 (ja) * 2005-01-10 2012-02-29 セクレタリー・デパートメント・オブ・アトミック・エナジー 被影響体のインビボ環境から放射性セシウム（＊Ｃｓ）、放射性ストロンチウム（＊Ｓｒ）、および放射性ヨウ素（＊Ｉ）を同時除染する予防混合物
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
WO2013148895A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
WO2013149075A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
WO2013148896A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular treatment solutions, delivery devices and delivery augmentation methods
WO2015080984A1 (en) 2013-11-27 2015-06-04 BioPharmX, Inc. Solid oral dosage form for breast symptoms
NZ721500A (en) 2014-02-10 2022-11-25 Fred Hutchinson Cancer Center Use of halogen compounds for the treatment and prevention of heart attack and ischemic injury
WO2017185060A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
KR102697203B1 (ko) 2016-07-21 2024-08-22 아이2퓨어 코프. 연화성 국소 소독제
WO2018053335A1 (en) * 2016-09-16 2018-03-22 Iogen Llc Oral molecular iodine composition and method
AU2019282820A1 (en) * 2018-06-08 2021-01-21 Faraday Pharmaceuticals, Inc. Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486317A (en) * 1981-01-16 1984-12-04 E. I. Du Pont De Nemours And Company Stabilization of thickened aqueous fluids
RO85156B1 (ro) * 1983-05-27 1984-11-30 Institutul De Stiinte Biologice Comprimate-reactiv pentru determinarea alfa-anilazei si procedeu de obtinere a acestora
CN1036629C (zh) * 1991-03-16 1997-12-10 李克亮 动物促长剂
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
AU1693099A (en) * 1998-01-06 1999-07-26 Fujisawa Pharmaceutical Co., Ltd. Solid preparation of iodophor and its manufacturing methods
US5985340A (en) * 1998-01-19 1999-11-16 Bolentica, Inc. Method for preparing iodine supplement for animal feeds

Also Published As

Publication number Publication date
NO20014101L (no) 2001-10-12
KR20010103014A (ko) 2001-11-17
AU778774B2 (en) 2004-12-23
DE10084290T1 (de) 2003-04-03
GB0122808D0 (en) 2001-11-14
BR0008509A (pt) 2002-02-05
AU3371300A (en) 2000-09-14
WO2000050046A8 (en) 2003-11-27
CA2366679C (en) 2007-05-01
KR100674324B1 (ko) 2007-01-24
FI20011703A0 (sv) 2001-08-24
JP2002537341A (ja) 2002-11-05
DK176595B1 (da) 2008-10-20
CA2366679A1 (en) 2000-08-31
ES2226514A1 (es) 2005-03-16
MXPA01008550A (es) 2003-08-19
IL144955A (en) 2006-12-31
AT413795B (de) 2006-06-15
ATA90122000A (de) 2005-10-15
ZA200106451B (en) 2002-08-06
DK200101258A (da) 2001-10-26
SE0102843L (sv) 2001-10-26
IL144955A0 (en) 2002-06-30
NO20014101D0 (no) 2001-08-23
FI20011703A (sv) 2001-10-16
CN1344163A (zh) 2002-04-10
GB2364641A (en) 2002-02-06
ES2226514B2 (es) 2007-02-16
WO2000050046A1 (en) 2000-08-31
GB2364641B (en) 2004-06-30
US6248335B1 (en) 2001-06-19

Similar Documents

Publication Publication Date Title
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
MY133996A (en) Compounds for the treatment of ischemia
ATE345782T1 (de) Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
IT1302682B1 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DK1185253T3 (da) Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
IL139318A (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
ATE254851T1 (de) Iod-herstellungszusammensetzung
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques
SE9902742D0 (sv) New pharmaceutical formultion
MY152490A (en) New oral formulation

Legal Events

Date Code Title Description
NAV Patent application has lapsed